Molecular Psychiatry, Journal Year: 2022, Volume and Issue: 27(3), P. 1562 - 1572
Published: Jan. 14, 2022
Language: Английский
Molecular Psychiatry, Journal Year: 2022, Volume and Issue: 27(3), P. 1562 - 1572
Published: Jan. 14, 2022
Language: Английский
Child and Adolescent Psychiatry and Mental Health, Journal Year: 2022, Volume and Issue: 16(1)
Published: March 31, 2022
To interpret the current evidence on prevalence of neurodevelopmental disorders (NDDs) through a systematic review based both DSM-5 (2013) and PRISMA criteria.Empirical studies complying with guidelines were identified from four databases (PubMed, Scopus, Science Direct, ProQuest) systematically reviewed. In total, 17 articles selected for study.In scientific literature, there have been only few measuring NDDs according to criteria in people under 18 years old. The reported rates as follows: intellectual disability (ID), 0.63%; attention-deficit/hyperactivity disorder (ADHD), 5-11%; autism spectrum (ASD), 0.70-3%; specific learning (SLD), 3-10%; communication (CDs), 1-3.42%; motor (MDs), 0.76-17%. Although is extensive literature disorders, rarely assessed whole. All reviewed support idea that such can be considered chronic, heterogeneous, underdiagnosed conditions comorbidity multiple norm. Likewise, it estimated most studied ADHD, ASD SLD, remains stable over time consistent different cultures, ages, ethnicities sexes.The lead us conclude rate fluctuates globally between 4.70 88.50%; these variations depend methodological aspects estimation procedures, well sociocontextual phenomena. It also important consider found probably highly influenced by activity countries diagnosis training professionals who care children adolescents. Hence, need secondary intervention fields public health education minimize socioemotional consequences, prevent academic failure, reduce economic cost society.
Language: Английский
Citations
173Nature Reviews Neurology, Journal Year: 2023, Volume and Issue: 19(3), P. 136 - 159
Published: Feb. 6, 2023
Language: Английский
Citations
117Journal of Affective Disorders, Journal Year: 2023, Volume and Issue: 339, P. 860 - 866
Published: July 24, 2023
Emerging epidemiological data suggest that hundreds of primary studies have examined the prevalence ADHD in children and adolescents dozens systematic view meta-analyses been conducted on subject. The purpose this umbrella review is to provide a robust synthesis evidence from these reviews meta-analyses.
Language: Английский
Citations
97Journal of Child Psychology and Psychiatry, Journal Year: 2022, Volume and Issue: 64(4), P. 506 - 532
Published: Oct. 11, 2022
The science of attention‐deficit/hyperactivity disorder (ADHD) is motivated by a translational goal – the discovery and exploitation knowledge about nature ADHD to benefit those individuals whose lives it affects. Over past fifty years, scientific research has made enormous strides in characterizing condition understanding its correlates causes. However, translation these insights into clinical benefits been limited. In this review, we provide selective focused survey field ADHD, providing our personal perspectives on what constitutes consensus, important new leads be highlighted, key outstanding questions addressed going forward. We cover two broad domains characterization and, risk factors, causal processes neuro‐biological pathways . Part one focuses developmental course co‐occurring characteristics conditions, functional impact living with including impairment, quality life, stigma. part two, explore genetic environmental influences putative mediating brain processes. final section, reflect future construct light cross‐cutting themes recent conceptual reformulations that cast traits as broader spectrum neurodivergence.
Language: Английский
Citations
83Molecular Psychiatry, Journal Year: 2023, Volume and Issue: 28(11), P. 4823 - 4830
Published: Sept. 8, 2023
Language: Английский
Citations
80Information Fusion, Journal Year: 2023, Volume and Issue: 99, P. 101898 - 101898
Published: June 25, 2023
Mental health is a basic need for sustainable and developing society. The prevalence financial burden of mental illness have increased globally, especially in response to community worldwide pandemic events. Children suffering from such disorders find it difficult cope with educational, occupational, personal, societal developments, treatments are not accessible all. Advancements technology resulted much research examining the use artificial intelligence detect or identify characteristics illness. Therefore, this paper presents systematic review nine developmental (Autism spectrum disorder, Attention deficit hyperactivity Schizophrenia, Anxiety, Depression, Dyslexia, Post-traumatic stress Tourette syndrome, Obsessive-compulsive disorder) prominent children adolescents. Our focuses on automated detection these using physiological signals. This also detailed discussion signal analysis, feature engineering, decision-making their advantages, future directions challenges papers published children. We presented details dataset description, validation techniques, features extracted models. present open questions availability, uncertainty, explainability, hardware implementation resources analysis machine deep learning Finally, main findings study conclusion section.
Language: Английский
Citations
78Nature Reviews Disease Primers, Journal Year: 2024, Volume and Issue: 10(1)
Published: Feb. 22, 2024
Language: Английский
Citations
72Virtual Reality, Journal Year: 2023, Volume and Issue: 27(4), P. 3545 - 3564
Published: Feb. 18, 2023
Abstract Virtual reality (VR) shows great potential in treating and managing various mental health conditions. This includes using VR for training or rehabilitation purposes. For example, is being used to improve cognitive functioning (e.g. attention) among children with attention/deficit-hyperactivity disorder (ADHD). The aim of the current review meta-analysis evaluate effectiveness immersive VR-based interventions improving deficits ADHD, investigate moderators effect size assess treatment adherence safety. included seven randomised controlled trials (RCTs) ADHD comparing controls waiting list, medication, psychotherapy, training, neurofeedback hemoencephalographic biofeedback) on measures cognition. Results indicated large sizes favour outcomes global functioning, attention, memory. Neither intervention length nor participant age moderated functioning. Control group type (active vs passive control group), diagnostic status (formal vs. informal) novelty technology were not significant Treatment was similar across groups there no adverse effects. should be cautiously interpreted given poor quality studies small sample.
Language: Английский
Citations
53The Lancet Psychiatry, Journal Year: 2023, Volume and Issue: 10(5), P. 323 - 333
Published: March 21, 2023
Language: Английский
Citations
49JAMA, Journal Year: 2024, Volume and Issue: 331(10), P. 850 - 850
Published: March 12, 2024
Importance Attention-deficit/hyperactivity disorder (ADHD) is associated with increased risks of adverse health outcomes including premature death, but it unclear whether ADHD pharmacotherapy influences the mortality risk. Objective To investigate initiation was reduced risk in individuals ADHD. Design, Setting, and Participants In an observational nationwide cohort study Sweden applying target trial emulation framework, we identified aged 6 through 64 years incident diagnosis from 2007 2018 no medication dispensation prior to diagnosis. Follow-up started until emigration, 2 after diagnosis, or December 31, 2020, whichever came first. Exposures defined as dispensing within 3 months Main Outcomes Measures We assessed all-cause well natural-cause (eg, physical conditions) unnatural-cause unintentional injuries, suicide, accidental poisonings). Results Of 148 578 (61 356 females [41.3%]), 84 204 (56.7%) initiated medication. The median age at 17.4 (IQR, 11.6-29.1 years). 2-year lower treatment strategy group (39.1 per 10 000 individuals) than noninitiation (48.1 individuals), a difference −8.9 (95% CI, −17.3 −0.6). significantly rate (hazard ratio [HR], 0.79; 95% 0.70 0.88) (2-year risk, 25.9 vs 33.3 individuals; difference, −7.4 −14.2 −0.5; HR, 0.75; 0.66 0.86), not 13.1 14.7 −1.6 −6.4 3.2; 0.86; 0.71 1.05). Conclusions Relevance Among diagnosed ADHD, mortality, particularly for death due unnatural causes.
Language: Английский
Citations
49